Opinion: Specialization improves return on capital in the life sciences
Executives who work for health care and life sciences organizations typically make strategic decisions based on where they expect to get the best returns for their investments. This strategy has been challenging due to growing pressures on pricing and declining returns.
Although diversification is often held up as the touchstone for decision-making, in this sphere, an emphasis on specialty-focused organizations may be wiser.
Read Original Article: Opinion: Specialization improves return on capital in the life sciences »
